Keratoconus Research
The Keratoconus Center is proud to offer more clinical trials for both treatment and understanding the basis of this disease than any other center in the world. Our clinical trials include:

• The early treatment of keratoconus with INTACS and the Intralase laser.
• Identifying genes in families with keratoconus.
• PRK (photorefractive keratectomy) for keratoconus.
• Treatment of mild to moderate keratoconus with INTACS and the Intralase laser.
• Treatment of keratoconus with the Visian ICL.
• Lamellar transplants in the treatment of  keratoconus.
• Developing a molecular genetic test to diagnose keratoconus.
• Videokeratography indices for detecting early keratoconus.

To date our research has significant contribution to the medical understanding, advances, and treatment of keratoconus. Our achievements include:

• Developed a computer software to early detect keratoconus.
• Identified the first molecular defect in keratoconus.
• The first group to demonstrate keratoconus has a genetic basis.
• The first group to publish and demonstrate that inserting INTACS with the Intralase laser is safer and more accurate than the mechanical technique.
• The first group in Los Angeles to offer the Intralase laser for corneal transplants in patients with keratoconus.

If you are interested in participating in our clinical trials please contact our research coordinator Martha Bucaram at 310-423-9642 or bucaramm@cshs.org.